North and Central Texas Clinical and Translational Science Initiative (KL2)

我们建议建立德克萨斯州北部和中部诊所

We propose to establish a North and Central Texas Clinical and Translational Science Initiative (NCTCTSI), which will be led by the University of Texas Southwestern Medical School at Dallas and will include many of the nation's leading schools of allopathic and osteopathic medicine, dentistry, nursing, pharmacy, public health, engineering and computer science - which have already formed a highly functional relationship supported by a Roadmap K12 award. We have established a Department of Clinical Sciences, which is supported by faculty from all participating schools and which will serve as the academic home for our CTSA. The Department provides academic appointments to clinical and translational investigators together with faculty whose expertise and research is focused on methodological disciplines common to all clinical research - in order to promote multidisciplinary team building and problem solving. The NCTCTSI will build on existing nationally-recognized programs supported by K30, M01 and Roadmap K12 awards and will integrate numerous institutional strengths to offer 10 highly innovative and fully integrated key functions: (1) faculty recruitment, development and recognition; (2) research education, training and career development; (3) research plan development and support; (4) scientific review and investment; (5) regulatory knowledge and support; (6) participant and clinical interactions resources; (7) novel research methodology development; (8) translational technologies and resources; (9) biomedical informatics; and (10) community engagement. Particular strengths are: (1) the substantial and unequivocal commitment of participating institutions to the Initiative (which have pledged ~ $125 million to the NCTCTSI over the next five years); (2) an established academic and cultural home that currently address many of the goals of the NIH; (3) > 200 established clinical and translational investigators who will act as faculty and mentors; (4) a highly innovative approach to integrating key functions that will act to create bonds among the members of a multidisciplinary academic community; (5) a large and medically diverse patient base cared for by internationally-renowned hospitals (which are strong supporters of this initiative); (6) > $150 million in annual peer-reviewed grant support for clinical studies; (7) superb infrastructure to support clinical and translational research; and (8) program leadership with the time, experience and commitment to ensure the success of the Initiative. The coordinated synthesis of these strengths will allow the NCTCTSI to contribute to the national CTSA consortium and thus help to identify best practices that will benefit clinical and translational research throughout the nation.